Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 2, 174 (1 April 2005) | doi:10.1038/ncponc0144
Advances in immunotherapy for chronic myeloid leukemia
Abstract
Bocchia M et al. (2005) Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial. Lancet 365: 657–662 Early results from an observational trial in Italy suggest that a new vaccine might improve outcomes in patients with chronic myeloid leukemia.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
